Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
R130
i
Other names:
R130, Recombinant oncolytic herpes simplex virus type 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Yunying Medicine
Drug class:
Cell death stimulant
Related drugs:
‹
TEQ103 (1)
CG0070 (1)
DNX-2401 (1)
AMUN-003 (0)
Ad-p53 gene therapy (0)
BI 1821736 (0)
CP-506 (0)
TRX-E-002-1 (0)
Clostridium novyi-NT (0)
DNX-2440 (0)
synthetic hypericin (0)
KM1 (0)
MV-NIS (0)
ruxotemitide (0)
RGV004 (0)
TG6050 (0)
VCN-01 (0)
YSCH-01 (0)
BBI-503 (0)
bendamustine hydrochloride (0)
ColoAd1 (0)
PT-112 (0)
RP1 (0)
TEQ103 (1)
CG0070 (1)
DNX-2401 (1)
AMUN-003 (0)
Ad-p53 gene therapy (0)
BI 1821736 (0)
CP-506 (0)
TRX-E-002-1 (0)
Clostridium novyi-NT (0)
DNX-2440 (0)
synthetic hypericin (0)
KM1 (0)
MV-NIS (0)
ruxotemitide (0)
RGV004 (0)
TG6050 (0)
VCN-01 (0)
YSCH-01 (0)
BBI-503 (0)
bendamustine hydrochloride (0)
ColoAd1 (0)
PT-112 (0)
RP1 (0)
›
Associations
News
Trials
Filter by
Latest
11ms
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors (clinicaltrials.gov)
P1, N=9, Recruiting, Shanghai Yunying Medical Technology
11 months ago
New P1 trial
|
IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
|
R130
over1year
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors (clinicaltrials.gov)
P1, N=20, Recruiting, Shanghai Yunying Medical Technology
over 1 year ago
New P1 trial • Oncolytic virus • IO biomarker • Metastases
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130
over1year
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors (clinicaltrials.gov)
P1, N=24, Recruiting, Shanghai Yunying Medical Technology
over 1 year ago
New P1 trial • Oncolytic virus • IO biomarker • Metastases
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130
over1year
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors (clinicaltrials.gov)
P1, N=20, Recruiting, Shanghai Yunying Medical Technology
over 1 year ago
New P1 trial • Oncolytic virus • IO biomarker • Metastases
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130
over1year
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors (clinicaltrials.gov)
P1, N=20, Recruiting, Shanghai Yunying Medical Technology
over 1 year ago
New P1 trial
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130
over1year
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer (clinicaltrials.gov)
P1, N=9, Recruiting, Shanghai Yunying Medical Technology
over 1 year ago
New P1 trial • Oncolytic virus • IO biomarker
|
IL6 (Interleukin 6) • CXCL8 (Chemokine (C-X-C motif) ligand 8) • IL2 (Interleukin 2) • IL10 (Interleukin 10) • IL4 (Interleukin 4)
|
R130
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login